6738556a0c25a5bcae8d0df9224.-oWXWFY7if2gQzACDbaweMie2xBeOxsD3k7k3u4lT2c.g73HPBVd_ozMdHM3aN_YGv7PqEAyb1NFvXeoj91RKh20zcYBPRb5zfo6aQ
11-20 European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading; Down More Than 7% for Week MT
11-20 BioVersys, GSK's Tuberculosis Drug Shows Early Bactericidal Activity in Phase 2a Trial MT
11-19 GSK's Velzatinib granted orphan drug designation in Japan for GIST AN
11-19 GSK's Receives Orphan Drug Designation for Gastrointestinal Cancer Drug in Japan MT
11-19 GSK Wins Japan's Orphan Drug Designation for Velzatinib in Gastrointestinal Stromal Tumor MT
11-18 GSK Gets US Approval for Lung Cancer Drug Nelkarmi MT
11-18 GSK Gets FDA Approval for New Lung-Cancer Drug DJ
11-18 GSK plc : RBC sticks Neutral ZD
11-18 GSK secures accelerated approval of Nelkarmi in US AN
11-17 GSK's Nelkarmi Gets US FDA Nod for Lung Cancer Treatment MT
11-17 Nelkarmi (neladalkib) approved in the US for previously-treated advanced ALK-positive non-small cell lung cancer BU
11-17 GSK Plc Receives Accelerated Approval For Nelkarmi In The US For Previously-Treated Advanced ALK-Positive Non-Small Cell Lung Cancer CI
11-17 GSK : Nelkarmi (neladalkib) approved in the US for previously-treated advanced ALK-positive non-small cell lung cancer PU
11-17 FDA Grants Accelerated Approval to GSK's Nelkarmi for ALK-Positive Lung Cancer MT
11-17 US FDA approves GSK's second lung cancer drug from historic Nuvalent deal RE
11-17 FDA grants accelerated approval to GSK's lung cancer drug RE
11-17 GSK plc : Jefferies reaffirms its Neutral rating ZD
11-17 Some profit-taking in GSK despite generally positive Jefferies comments Zonebourse
11-16 European Equities Traded in the US as American Depositary Receipts Kick Off Week Lower in Monday Trading MT
11-16 GSK's ViiV Healthcare Gets EMA Committee's Recommendation to Expand Use of HIV Drugs MT
11-13 GSK PLC Receives Positive CHMP Opinion For Bexsero Booster CI
11-13 GSK's Meningococcal Disease Vaccine Gets EU Recommendation for Newborns MT
11-13 GSK gets support from EU panel for Meningitis B booster in adolescents AN
11-13 EU Medicines Agency Panel Recommends Booster Dose of GSK's Bexsero MT
11-09 Vocabria + Rekambys associated with greater adherence versus daily oral therapy in a US real-world study, as ViiV Healthcare presents broader long-acting portfolio and pipeline data at HIV Glasgow BU

Become a member to access more news

New member
No results match your criteria
  1. Stock Market
  2. Stocks
  3. GSK Stock
  4. Stock
  5. News GlaxoSmithKline plc